Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=collection%3ACTG&lookfor=%22diagnosis%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=collection%3ACTG&lookfor=%22diagnosis%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=collection%3ACTG&lookfor=%22diagnosis%22&type=Subject
PubPharm (1.649)
1
Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers : Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
2
Chymase inhibitor BAY 1142524 in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease : A randomized, double-blind, multicenter study to assess the efficacy and safety of a 6 month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on top of standard of care in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. - Pre-operative study of Lapatanib in DCIS : Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. - Pre-operative study of Lapatanib in DCIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
BI 425809 in patients with cognitive impairment due to Alzheimer's Disease. : A multi-centre, double-blind, parallel-group, randomised controlled study to investigate efficacy and safety of orally administered BI 425809 during a 12-week treatment period compared to placebo in patients with cognitive impairment due to Alzheimer's Disease.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
Chymase inhibitor BAY 1142524 in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease : A randomized, double-blind, multicenter study to assess the efficacy and safety of a 6 month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on top of standard of care in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
A MULTICENTER, OPEN LABEL, RANDOMIZED PHASE II STUDY COMPARING DARATUMUMAB combined with BORTEZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE (Dara-VCd) VERSUS THE ASSOCIATION OF BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTd) AS PRE TRANSPLANT INDUCTION AND POST TRANSPLANT CONSOLIDATION, BOTH FOLLOWED BY A MAINTENANCE PHASE WITH IXAZOMIB ALONE OR IN COMBINATION WITH DARATUMUMAB, IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) YOUNG PATIENTS eligible for AUTOLOGOUS STEM CELL TRANSPLANTATION : A MULTICENTER, OPEN LABEL, RANDOMIZED PHASE II STUDY COMPARING DARATUMUMAB combined with BORTEZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE (Dara-VCd) VERSUS THE ASSOCIATION OF BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTd) AS PRE TRANSPLANT INDUCTION AND POST TRANSPLANT CONSOLIDATION, BOTH FOLLOWED BY A MAINTENANCE PHASE WITH IXAZOMIB ALONE OR IN COMBINATION WITH DARATUMUMAB, IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) YOUNG PATIENTS eligible for AUTOLOGOUS STEM CELL TRANSPLANTATION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
Chymase inhibitor BAY 1142524 in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease : A randomized, double-blind, multicenter study to assess the efficacy and safety of a 6 month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on top of standard of care in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. - Pre-operative study of Lapatanib in DCIS : Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. - Pre-operative study of Lapatanib in DCIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
BI 425809 in patients with cognitive impairment due to Alzheimer's Disease. : A multi-centre, double-blind, parallel-group, randomised controlled study to investigate efficacy and safety of orally administered BI 425809 during a 12-week treatment period compared to placebo in patients with cognitive impairment due to Alzheimer's Disease.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
Chymase inhibitor BAY 1142524 in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease : A randomized, double-blind, multicenter study to assess the efficacy and safety of a 6 month oral treatment with the chymase inhibitor BAY 1142524 at a dose of 25 mg BID in comparison to placebo on top of standard of care in patients with type II diabetes and a clinical diagnosis of diabetic kidney disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[165]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
1.649
Aufsätze
1.649
E-Artikel
1.649
E-Ressourcen
Zeitschriftentitel
1.472
WHO International Clinical Trials Registry Plat...
177
ClinicalTrials.gov
Thema
1.649
610
1.554
Study Type: Interventional
936
Recruitment Status: Not yet recruiting
372
Recruitment Status: Authorised-recruitment may ...
238
Phase: Phase 2
227
Recruitment Status: Completed
174
Phase: Phase 3
99
Phase: Phase 4
70
Study Type: Observational
57
Recruitment Status: Unknown status
26
Phase: Phase 1
26
Recruitment Status: Recruiting
24
Medical Condition: Male or female patients, wit...
16
Study Type: Observational [Patient Registry]
14
Medical Condition: Recently diagnosed (1-5 year...
10
Medical Condition: Patients who have a document...
10
Medical Condition: Patients with suspected pros...
10
Medical Condition: The medical condition for th...
10
Phase: Phase 2/Phase 3
9
Mental Disorders
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
270
2019
234
2018
189
2017
125
2016
129
2015
139
2014
145
2013
411
2012
6
2011
1
2010
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.629
Englisch
10
Unbestimmt
4
Französisch
4
Spanisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...